Status:
COMPLETED
Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Depression
Lead Sponsor:
Xijing Hospital
Collaborating Sponsors:
The No.3 hospital of PLA
The No.91 hospital of PLA
Conditions:
Depression
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of repetitive transcranial magnetic stimulation in the prevention of relapse of the symptoms of depression. Primary Outcome Measures:Time between ...
Detailed Description
Transcranial magnetic stimulation is a noninvasive technique that can influence specific areas of the brain and has very few side effects.Several factors characterize repetitive transcranial magnetic ...
Eligibility Criteria
Inclusion
- DSM-IV diagnosis of depression
- Experiencing an acute exacerbation of depression symptoms
- Baseline score of at least 14 points on the Hamilton Depression rating Scale-17 items
- Healthy based on physical examinations, electrocardiogram (ECG), laboratory tests, medical history, and vital signs measurements
Exclusion
- Comprised ferromagnetic metallic implants
- Pacemakers
- Previous neurosurgery
- History of seizures
- Major head trauma
- Alcoholism
- Drug addiction
- Any psychiatric or neurological disorder other than depression and anxiety
- Psychotic depression
- Suicidal propensities
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 25 2017
Estimated Enrollment :
391 Patients enrolled
Trial Details
Trial ID
NCT01516931
Start Date
January 1 2013
End Date
February 25 2017
Last Update
January 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qingrong
Xi'an, Shaanxi, China, 710032